Basilea Pharmaceutica AG
BPMUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -21.4% | 73.3% | 4.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.9% | 109.9% | 32.2% | 76.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 24.1% | 42.5% | 13.3% | 4.3% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 15.2% | 43% | 27.2% | -29.4% |
| EPS Diluted | 1.26 | 4.2 | 1.5 | -1.78 |
| % Growth | -70% | 180% | 184.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |